Talindrew vs Geneious

Geneious Prime is a broad desktop bioinformatics suite covering NGS assembly, phylogenetics and alignment as well as cloning. Talindrew is narrower and browser-native, focused on construct design plus structure and drug discovery.

When Geneious is the better choice

Choose Geneious if you need NGS read mapping and assembly, phylogenetic tree building, multiple sequence alignment or microsatellite genotyping. Talindrew does none of these.

When Talindrew is the better choice

Choose Talindrew if your work is construct design rather than genomics analysis, and you would rather not pay a per-seat annual licence to open a plasmid.

Talindrew vs Geneious, feature by feature

Feature comparison between Talindrew and Geneious
FeatureTalindrewGeneious
Access
Free tierGeneious Prime offers a free trial and free course licences for teaching, but no permanent free plan. Personal subscriptions run $200–$2,150/year.YesNo
Browser-native (no install)YesNo
Works offlineNoYes
Editing
Linear sequence editorYesYes
Circular plasmid mapYesYes
Multi-format importYesYes
Cloning
Cloning design wizardsYesYes
Analysis
Restriction digestYesYes
Agarose gel simulationYesYes
Pairwise alignmentYesYes
Multiple sequence alignmentNoYes
Genomics
NGS read mapping and assemblyNoYes
Phylogenetic tree buildingNoYes
Plugin ecosystemNoYes
Structure
Protein structure predictionESMFoldPlugin
Drug discovery pipelineYesNo
AI
Sequence-aware AI assistantYesNo

Talindrew vs Geneious: common questions

Is Geneious free?
No. Geneious Prime has a free trial and offers free course licences to professors teaching a class, but there is no permanent free tier. Personal subscriptions range from roughly $200/year for students to $2,150/year for corporate users. Talindrew is free to start.
What does Geneious do that Talindrew does not?
Geneious Prime covers NGS read mapping and assembly, phylogenetic tree building, multiple sequence alignment, microsatellite genotyping and a plugin ecosystem. Talindrew does not do genomics analysis at all — it focuses on construct design, structure prediction and drug discovery.

Explore the platform

Ready to try the browser-native alternative?

Start for free — no account needed